trending Market Intelligence /marketintelligence/en/news-insights/trending/8-d1AWCpxacYLGS6hn_7EQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Zimmer Biomet's robot-assisted system gets US FDA approval for spine surgeries

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Zimmer Biomet's robot-assisted system gets US FDA approval for spine surgeries

Zimmer Biomet Holdings Inc. said its robot-assisted system Rosa was approved by the U.S. Food and Drug Administration for spine surgeries.

The Rosa spine system received FDA's 510(k) clearance, which authorizes Zimmer to market the device as safe and effective, or substantially equivalent, to a legally marketed device.

Zimmer Biomet's Rosa spine system provides surgeons tools and real-time data that help improve implant procedures and instrument placement accuracy.

The FDA has also approved the Warsaw, Ind.-based medical device-maker's Rosa systems for brain and knee surgeries.